Glooko is a company startup that makes diabetes management easier, whether it is a person with diabetes, a clinician, or a disease management organization. Glooko’s FDA 510(k) cleared, HIPAA compliant diabetes management system starts with adding simplicity to keeping a logbook. With the Glooko mobile app and Glooko MeterSync Cable, patients can seamlessly download meter readings from a multitude of FDA-cleared glucose meters into their mobile device. This data is now accessible, annotatable, and sharable. Information uploaded by the patient can be shared with their provider through Glooko’s integrated online platform, available on supported web browsers.

Mountain View, US
Size (employees)
127 (est)+3%
Glooko was founded in 2010 and is headquartered in Mountain View, US
Report incorrect company information

Key People/Management at Glooko

Rick Altinger

Rick Altinger

Yogen Dalal

Yogen Dalal

Co-founder & Chairman
Michael Greenfield

Michael Greenfield

Chief Medical Officer

Glooko Office Locations

Glooko has an office in Mountain View
Mountain View, US (HQ)
899 W Evelyn Ave
Show all (1)
Report incorrect company information

Glooko Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$71 m

Latest funding size

$35 m

Time since last funding

a year ago


Glooko's latest funding round in June 2017 was reported to be $35 m. In total, Glooko has raised $71 m
Show all financial metrics

Glooko Operating Metrics

Glooko's Patients was reported to be 1 m in Jun, 2017.
Jun, 2017


1 m

Service Providers

6 k
Show all operating metrics
Report incorrect company information

Glooko News and Updates

Diabetes management platform Glooko raises $35 million

 Glooko, a startup selling data management healthcare service on top of a device-agnostic platform to make it easier for doctors to remotely monitor patients, has pulled in $35 million Series C funding. It had previously raised $36 million in various rounds, bringing the total up to $71 million. The…

Georgian Partners leads $35 mln Series C financing of Glooko

Glooko, a U.S. diabetes data management platform, has secured $35 million in Series C financing. The round was led by Canadian growth equity firm Georgian Partners and joined by new and existing investors, including Canaan Partners, Medtronic and Social Capital. Founded in 2010, Glooko is a develope…
Report incorrect company information